Interactions Between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases
Total Page:16
File Type:pdf, Size:1020Kb
Journal of Lipids Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases Guest Editors: David Q.-H. Wang, Brent A. Neuschwander-Tetri, Piero Portincasa, and William M. Pandak Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases Journal of Lipids Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases Guest Editors: David Q.-H. Wang, Brent A. Neuschwander-Tetri, Piero Portincasa, and William M. Pandak Copyright © 2012 Hindawi Publishing Corporation. All rights reserved. This is a special issue published in “Journal of Lipids.” All articles are open access articles distributed under the Creative Commons At- tribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Editorial Board Maurizio Averna, Italy Xian-Cheng Jiang, USA Robert Salomon, USA Rhoderick Brown, USA Gerhard M. Kostner, Austria Gerd Schmitz, Germany Teodor Brumeanu, USA RumianaKoynova,USA Aleksander F. Sikorski, Poland Angel Catala, Argentina Arkadiusz Kozubek, Poland Roland Verhe,´ Belgium Michael A. Crawford, UK Stan Kubow, Canada Rosemary Lee Walzem, USA J. F. Glatz, The Netherlands M. Lagarde, France Philip W. Wertz, USA Bruce Griffin, UK Clifford A. Lingwood, Canada W. Gibson Wood, USA J. A. Hamilton, USA Shinichi Oikawa, Japan Xuebing Xu, Denmark Xianlin Han, USA Sampath Parthasarathy, USA Teruyoshi Yanagita, Japan Walter M. Holleran, USA Javier S. Perona, Spain Zemin Yao, Canada Akihiro Inazu, Japan Alessandro Prinetti, Italy David J. A. Jenkins, Canada U. Ravnskov, Sweden Contents Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases, David Q.-H. Wang, Brent A. Neuschwander-Tetri, Piero Portincasa, and William M. Pandak Volume 2012, Article ID 560715, 2 pages A Pleiotropic Role for the Orphan Nuclear Receptor Small Heterodimer Partner in Lipid Homeostasis and Metabolic Pathways, Gabriella Garruti, Helen H.Wang, Leonilde Bonfrate, Ornella de Bari, David Q.-H.Wang, and Piero Portincasa Volume 2012, Article ID 304292, 22 pages Nuclear Receptor Variants in Liver Disease,RomanMullenbach,¨ Susanne N. Weber, and Frank Lammert Volume 2012, Article ID 934707, 12 pages Fatty Acid Oxidation and Cardiovascular Risk during Menopause: A Mitochondrial Connection?, Paulo J. Oliveira, Rui A. Carvalho, Piero Portincasa, Leonilde Bonfrate, and Vilma A. Sardao Volume 2012, Article ID 365798, 12 pages Nuclear Receptors in Nonalcoholic Fatty Liver Disease, Jorge A. Lopez-Vel´ azquez,´ Luis D. Carrillo-Cordova,´ Norberto C. Chavez-Tapia,´ Misael Uribe, and Nahum Mendez-S´ anchez´ Volume 2012, Article ID 139875, 10 pages Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target, Michael Fuchs Volume 2012, Article ID 934396, 8 pages Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease, Ornella de Bari, Brent A. Neuschwander-Tetri, Min Liu, Piero Portincasa, and David Q.-H. Wang Volume 2012, Article ID 302847, 16 pages Molecular Mechanisms Underlying the Link between Nuclear Receptor Function and Cholesterol Gallstone Formation, Mary Carmen Vazquez,´ Attilio Rigotti, and Silvana Zanlungo Volume 2012, Article ID 547643, 7 pages Bile Acid Signaling in Liver Metabolism and Diseases, Tiangang Li and John Y. L. Chiang Volume 2012, Article ID 754067, 9 pages Hindawi Publishing Corporation Journal of Lipids Volume 2012, Article ID 560715, 2 pages doi:10.1155/2012/560715 Editorial Interactions between Bile Acids and Nuclear Receptors and Their Effects on Lipid Metabolism and Liver Diseases David Q.-H. Wang,1 Brent A. Neuschwander-Tetri,2 Piero Portincasa,3 and William M. Pandak4 1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Edward Doisy Research Center, Saint Louis University School of Medicine, 1100 S. Grand Boulevard, St. Louis, MO 63104, USA 2 Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, 3635 Vista Avenue, St. Louis, MO 63110, USA 3 Clinica Medica “A. Murri”, Department of Interdisciplinary Medicine (DIM), University of Bari School of Medicine, Policlinico Hospital, Piazza G. Cesare 11, 70124 Bari, Italy 4 Division of Gastroenterology and Hepatology, Department of Medicine, Virginia Commonwealth University Health Sciences Center & Veterans Affairs Medical Center, P.O. Box 980341, Richmond, VA 23298, USA Correspondence should be addressed to David Q.-H. Wang, [email protected] Received 15 January 2012; Accepted 15 January 2012 Copyright © 2012 David Q.-H. Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In this special issue of Journal of Lipids, we acknowledge the lipid metabolism. Besides their detergent properties and key contributionsbyseveralexpertsoffering timely perspectives physiological functions, bile acids are also acting as potent on the complex interactions between bile acids and nuclear metabolic regulators of glucose and lipid homeostasis. The receptors (NRs) on lipid metabolism and liver diseases at identification of bile acid-activated nuclear receptor farne- different levels and contexts in the body. soid X receptor (FXR) and cell surface G-protein-coupled NRs are found within the interior of cells and are defined receptor TGR5 has significantly advanced our understanding as ligand-activated transcriptional regulators of several key on how bile acid signaling regulates cellular metabolism in aspects of body physiology and pathophysiology. NRs regu- health and disease. Thus, novel therapeutic strategies can be late gene transcription through interaction with cellular envisioned which target bile acid metabolism for the treat- coactivators and corepressors. In the liver, NRs play a key role ment of metabolic disorders such as obesity, insulin resist- in a large variety of metabolic processes such as cholesterol, ance, and the metabolic syndrome. bile acid, fatty acid, and glucose homeostasis, as well as drug NRs comprise one of the most abundant classes of tran- disposition. Also, additional critical processes involving the scriptional regulators of metabolic diseases and have pathophysiology of liver diseases—inflammation and fibro- emerged as promising pharmaceutical targets. The paper by sis, regeneration, cell differentiation, and tumor formation— G. Garruti et al. deals with the myriad roles of small het- are modulated by NRs. Of note, NRs are or might soon be- erodimer partner (SHP), a unique orphan nuclear receptor come drug targets. Despite the huge accumulation of knowl- lacking a DNA-binding domain, but containing a putative edge in the field, the true comprehension of interactions ligand-binding domain. About half of mammalian NRs and between bile acids and NRs on lipid metabolism and hepato- several transcriptional coregulators can interact with SHP. biliary diseases has remained elusive. Thus continuous efforts SHP is a transcriptional regulator affecting multiple key bi- are being made to understand the molecular functions of ological functions and metabolic processes including choles- NRs, the significance of bile acid-controlled signaling path- terol, bile acid, and fatty acid metabolism, as well as repro- ways, and interactions of NRs on a number of metabolic and ductive biology and glucose-energy homeostasis. In humans, hepatic diseases. studies are emerging on the association of SHP genetic The paper of T. Li and Y. L. Chiang is focused on the role variation with birth weight, high body mass index, obesity, of bile acid signaling in the regulation of glucose and insulin resistance, and diabetes. Future research must be 2 Journal of Lipids focused on synthetic ligands acting on SHP as a potential crucial steps include fat storage, export, uptake, oxidation, therapeutic target in a series of metabolic abnormalities. and lipolysis. A whole family of NRs is targeted by many One important issue in lipidology is the understanding ligands controlling lipid metabolism including fatty acids, of the molecular mechanisms whereby cholesterol and fatty oxysterols, and lipophilic molecules. Understanding the acids are absorbed from the intestine and are transported molecular mechanisms underlying the involvement of NRs to the liver. The cholesterol absorption inhibitor ezetimibe in the pathogenesis of NAFLD may, therefore, offer targets can significantly reduce plasma total and LDL cholesterol for the development of new treatments of one of the most concentrations by inhibiting the Niemann-Pick C1-like 1 frequent chronic liver diseases worldwide. protein (NPC1L1), an intestinal sterol influx transporter that In their paper, R. Mullenbach¨ et al. provided an update can actively facilitate the uptake of cholesterol for intestinal on genetic variants of NRs involved in regulating important absorption. The paper by O. de Bari et al. emphasizes the aspects of liver metabolism. One such aspect is the applica- novel concept that, ezetimibe treatment also induces a com- tion of NRs in genetic diagnosis of monogenic (Mendelian) plete resistance to two frequent metabolic abnormalities, liver diseases and their uses in clinical diagnosis. Moreover, namely, cholesterol gallstones and nonalcoholic fatty liver a role